Navigation Links
Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
Date:4/22/2008

SANTA MONICA, Calif., April 22 /PRNewswire-FirstCall/ -- Aida Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) today announced the availability of an investor-focused corporate synopsis on its English language website, http://en.aidapharma.com, which may be downloaded as a pdf document. The synopsis details Aida Pharmaceuticals, Inc.'s public company financial information, current product line, the drugs in its development pipeline, as well as its future growth avenues.

About Aida Pharmaceuticals

Aida Pharmaceuticals, Inc. is a product-focused pharmaceuticals company engaged in the formulation, clinical testing, registration, manufacture, sales and marketing of advanced pharmaceutical and genetic products in mainland China. The Company's mission is to discover, develop and market meaningful new therapies that improve human health. Aida Pharmaceuticals, Inc., in operation since March 1999, is headquartered in Hangzhou, the People's Republic of China (the "PRC") with manufacturing, distribution and sales points throughout mainland China. Aida Pharmaceuticals, Inc. is GMP certified in the PRC and ISO9002 certified for quality assurance and ISO14000 certified for ecologically-friendly practices.

Contact Information:

Ashley Hull

(310) 450-9100 opt 1

ashley@leacapital.com

Broker Contact:

Chesapeake Group

(410) 825-3930

Safe Harbor Statement Under The Private Securities Litigation Reform Act of 1995: Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ
'/>"/>

SOURCE Aida Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
7. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
8. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
9. Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
10. Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
11. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Voyant Health™ announced today tha...ensed its TraumaCad Enterprise orthopedic templati...tion. , (PRWEB) November ...hat Spectrum Health (Grand Rapids, Michigan) has l...ting solution and its TraumaCad Extend workflow so...
(Date:11/27/2009)... Specialist manufacturers who use medical...ing millions of dollars by bringing in technology ...asing numbers of pro-active medical manufacturers ...ncept stage of their projects, ensuring that progr...cesses or potentially outdated technology. , ...
(Date:11/26/2009)...Nov.27/PRNewswire/--Withcoldandfluseasonuponus,it,...olthespreadofinfectionsandavoidillness. ,, "Wen...oavoidtransmittingillnessifwe,resick,"saidEileenFi...ingdirectorforinfectioncontrolandoccupationalhealt..., HospitalforSpecialSurgeryhasoneofthelowestinfect...
(Date:11/26/2009)... years, the number of Americans living with diabet...n in 2009 to 44.1 million in 2034. Over the same p...sing from $113 billion to $336 billion, even with ...ers based at the University of Chicago report in t...er of those with diabetes covered by Medicare will...
(Date:11/26/2009)...oo big or too heavy can lead to strains or worse ,... There may be nothing wrong with stuffing your tur... the same thing with your suitcase as you pack for...treated in 2008 in U.S. hospital emergency rooms, ...ties for luggage-related injuries, such as muscle ...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2
...ccording to a recent study in the U.S, divorce aff... Fred Lorenz, who co-authored the report at Iowa S...ural Research, said: “What we found was that the a...s on mental health led to effects in physical heal...
... recent study reveals that 1-in-8 children with ty... The allergy to gluten, largely present in w...rized by intestinal cramping, pain, bloating, diar...ng-term effects on growth were restored. D...
... hospital in London has developed a flat computer ...es of methicillin-resistant staphylococcus // aure...fections that kill 5,000 people each year in Brita...ance to most penicillins. Research shows tha...
...ospital wards in some of Russia's most remote loca...ores of patients, almost exclusively men, have bee...ng as a result of drinking bootleg vodka. Hund...ost of the numerous victims taken to hospitals ove...
...easure your waist regularly, because the size of y...racting cardiovascular diseases, // according to n...n origin. According to Kamlesh Khunti, senior c...rently over half of women and two-thirds of men in...
...hile the government officials continue to extol th...ve taken to the streets to protest against the pol...ecounts tales of falling waiting lists and increas...isastrous policies. Pensioners and health staf...
Other Medicine News:Health News:New Flat Keyboard To Tackle Hospital Super Bug 2Health News:Russia Hit By Cheap Bootleg Vodka Epidemic 2Health News:Wide Differences between NHS staff and ministers 2
(Date:11/25/2009)...ccordingtoMillenniumResearchGroup(MRG),theglobalau...arly$3billionUSmarketfortraumafixationdeviceswillc...therecenteconomicslowdown.MRG,s USMarketsforTrauma...ighlydynamicoverthenextfiveyears,withcompetitorsin...segmentsofthetraumafixationmarket,fuelingmarketgro...
(Date:11/25/2009)...-CempraPharmaceuticalsInc.todayannouncedthatPrabha...illpresentatthePiperJaffray21stAnnualHealthCareCon...laceHotelinNewYorkCity.Dr.Fernandeswillprovideanov...ogramsforthetreatmentofdrug-resistantpathogensincl..., Foundedin2006,CempraPharmaceuticalsisaprivately-...
(Date:11/25/2009)...inker.comannouncesthatanewmarketresearchreportisav...ry-USMarketTrends&Analysis http://www.reportl...arket-Trends--Analysis.html ,, TheUSintranasal...uticapplicationsfromthedeliveryofconventionallocal...drugs.Thefutureofthetechnologyhingesontotheeffecti...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Allsup Outlines Role of Social Security Disability Insurance for Obtaining Medicare Benefits 56509 1Allsup Outlines Role of Social Security Disability Insurance for Obtaining Medicare Benefits 56509 2Allsup Outlines Role of Social Security Disability Insurance for Obtaining Medicare Benefits 56509 3Allsup Outlines Role of Social Security Disability Insurance for Obtaining Medicare Benefits 56509 4First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 1First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 2First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 3Work conditions impact parents food choices 9834 1Work conditions impact parents food choices 9834 2
... presented at American College of Rheumatology Ann...uibb Company,(NYSE: BMY ) today announced the res... pivotal trials that showed ORENCIA(R) (abatacept)...rk or household chores, physical and,social-role i...arthritis,(RA) patients who have had an inadequate...
... ANTIPOLIS, France, Nov. 12 NicOx S.A.,(Eurolist:...pivotal phase 3,trial for naproxcinod in patients ...re presented on November 10, 2007 at the 71st annu... (ACR), in Boston, Massachusetts (see,NOTE). Napro... and the,first compound in the COX-Inhibiting Nitr...
Other Medicine Technology:Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 2Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 3Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 4Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 5Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 6Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 7Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 8Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 9NicOx' Naproxcinod Phase 3 Results Presented at American College of Rheumatology 2NicOx' Naproxcinod Phase 3 Results Presented at American College of Rheumatology 3NicOx' Naproxcinod Phase 3 Results Presented at American College of Rheumatology 4
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: